Aidapak Recalls Thyroid Tablets Due to Potential Label Mixup
Aidapak Services, LLC is recalling 30 mg Thyroid tablets because they may have been mislabeled as other prescription drugs.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error (label mixup) without reported illnesses or injuries, fitting the criteria for moderate severity.
Plain-English summary
Aidapak Services, LLC is recalling 300-tablet bottles of THYROID, Tablet, 30 mg (NDC 00456045801) due to a potential label mixup. The recalled thyroid tablets may have been mislabeled as Omeprazole/Sodium Bicarbonate capsules, Nicotine Polacrilex lozenges, or Pyridoxine HCl tablets.
The affected thyroid tablets have pedigree codes AD65323_1, AD73611_1, or W002847, with expiration dates of May 29, 2014, May 30, 2014, or June 7, 2014. These repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Consumers who have these specific thyroid tablets should stop using them and contact their pharmacist or healthcare provider for guidance. The recall is classified as FDA Class II, indicating a reasonable probability of temporary or medically reversible adverse health consequences.
The recalled product
- Product
- THYROID, Tablet, 30 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00456045801.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 300
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- THYROID
- Tablet
- 30 mg has the following codes: Pedigree: AD65323_1
- EXP: 5/29/2014
- Pedigree: AD73611_1
- EXP: 5/30/2014
- Pedigree: W002847
- EXP: 6/7/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateAidapak Recalls Torsemide Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Hydrochlorothiazide Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- SevereAidapak Recalls Tramadol Tablets Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateFDA Recalls Tizanidine Tablets Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Glimepiride Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- HighAripiprazole Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-22